Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -241.58%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-531.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-618.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-206.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-136.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-52.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
GlucoTrack, Inc.
Market Cap
$893920.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-531.22%
3Y Avg
-618.53%
5Y Avg
-206.97%
Market Cap
$877747.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-272.49%
3Y Avg
-270.70%
5Y Avg
-191.72%
Market Cap
$897948.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-90.63%
3Y Avg
-141.82%
5Y Avg
-116.81%
Market Cap
$815044.00
Return on Invested Capital (ROIC)
-77.55%
TTM Avg
-118.09%
3Y Avg
-161.88%
5Y Avg
-137.96%
Market Cap
$1.01M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$693655.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$1.09M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.13M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
Market Cap
$1.16M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GlucoTrack, Inc. (GCTK) | $893920.00 | N/A | -531.22% | -618.53% | -206.97% |
| Decoy Therapeutics Inc. (DCOY)vs › | $877747.00 | -343.55% | -272.49% | -270.70% | -191.72% |
| Bone Biologics Corporation (BBLG)vs › | $897948.00 | -78.01% | -90.63% | -141.82% | -116.81% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $815044.00 | -77.55% | -118.09% | -161.88% | -137.96% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -59.81% | -3.58% | -5.96% | -5.96% |
| CDT Equity Inc. (CDT)vs › | $693655.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | -60.41% | -162.02% | -321.37% | -223.75% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.13M | -9.45% | -4.19% | 5.39% | 5.39% |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | -128.95% | -69.60% | -67.51% | -50.89% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.15M | -709.40% | -164.13% | -164.13% | -164.13% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -241.58% |
| 2025-09-30 | -967.39% |
| 2025-06-30 | -425.02% |
| 2025-03-31 | -390.80% |
| 2024-12-31 | -631.30% |
| 2024-03-31 | -2195.03% |
| 2023-12-31 | -354.55% |
| 2023-09-30 | -26.58% |
| 2023-06-30 | -35.56% |
| 2023-03-31 | -1355.39% |
| 2022-12-31 | -180.63% |
| 2022-09-30 | -109.62% |
| 2022-06-30 | -132.67% |
| 2022-03-31 | -95.36% |
| 2021-12-31 | -75.07% |
| 2021-09-30 | 42.32% |
| 2021-06-30 | 36.29% |
| 2021-03-31 | 35.24% |
| 2020-12-31 | 33.82% |
| 2020-09-30 | -16.23% |
| 2020-06-30 | -16.37% |
| 2020-03-31 | -17.76% |
| 2015-06-30 | 64.14% |
| 2015-03-31 | 43.54% |
| 2014-12-31 | 33.54% |
| 2014-09-30 | 39.31% |
| 2013-09-30 | 88.60% |
| 2013-06-30 | 70.36% |
| 2013-03-31 | 55.37% |
| 2012-03-31 | 91.42% |
| 2011-12-31 | 59.95% |
